-Edith A Perez Researcher Activity Profile

Research Author Detailed Information 

Edith A Perez Publication Rate By Year

Edith A Perez has published 3 paper(s) in 2006, 17 paper(s) in 2007, 3 paper(s) in 2008, for a total of 23 research publications in total.

Edith A Ea Perez Author Information

LAST NAME: perez

FIRST NAME: Edith A

INITIALS: ea

AFFILIATION:

Papers

Edith A Perez's Publication Record

1. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Year Published: 2006
Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
2. Appraising adjuvant aromatase inhibitor therapy. Year Published: 2006
Mayo Clinic, Jacksonville, Florida 32224, USA. perez.edith@mayo.edu
3. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Year Published: 2007
Department of Oncology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN , 55905, USA, goetz.matthew@mayo.edu.
4. Managing high-risk breast cancer. Year Published: 2007
Breast Clinic and Breast Cancer Program, Mayo Clinic, FL 32224, USA. Palmieri.Frances@mayo.edu
5. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Year Published: 2007
Mayo Clinic, Scottsdale, AZ, USA.
6. Is there a gluteus medius tendon injury during reaming through a modified medial trochanteric portal? A cadaver study. Year Published: 2007
Campbell Clinic, University of Tennessee, Memphis, TN 38104, USA. ep1141@hotmail.com
7. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Year Published: 2007
Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
8. Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer. Year Published: 2007
Department of Pharmacy, University of Washington, Seattle, Washington, USA. lgarrisn@u.washington.edu
9. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Year Published: 2007
Mayo Clinic, Jacksonville, FL, USA.
10. Safety of aromatase inhibitors in the adjuvant setting. Year Published: 2007
Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. perez.edith@mayo.edu
11. Is there a gluteus medius tendon injury during reaming through a modified medial trochanteric portal? A cadaver study. Year Published: 2007
Campbell Clinic, University of Tennessee, Memphis, TN 38104, USA. ep1141@hotmail.com
12. Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer. Year Published: 2007
Department of Pharmacy, University of Washington, Seattle, Washington, USA. lgarrisn@u.washington.edu
13. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. Year Published: 2007
Indiana University Cancer Center, Indianapolis, USA. kathmill@iupui.edu
14. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. Year Published: 2007
Indiana University Cancer Center, Indianapolis, USA. kathmill@iupui.edu
15. Use of the Vectra Polyetherurethaneurea Graft for Dialysis Access in HIV-Positive Patients With End-Stage Renal Disease. Year Published: 2008
Division of Vascular Surgery, University of Miami School of Medicine, Miami, Florida. fschild@med.miami.edu.
16. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. Year Published: 2007
Indiana University Cancer Center, Indianapolis, USA. kathmill@iupui.edu
17. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Year Published: 2007
Mayo Clinic, Jacksonville, FL, USA. perez.edith@mayo.edu
18. Use of the Vectra polyetherurethaneurea graft for dialysis access in HIV-positive patients with end-stage renal disease. Year Published: 2008
Division of Vascular Surgery, University of Miami School of Medicine, Miami, Florida, USA. fschild@med.miami.edu
19. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. Year Published: 2006
DeWitt Daughtry Family Department of Surgery and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
20. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Year Published: 2007
Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
21. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Year Published: 2007
Mayo Clinic, Jacksonville, FL, USA. perez.edith@mayo.edu
22. Is there a gluteus medius tendon injury during reaming through a modified medial trochanteric portal? A cadaver study. Year Published: 2007
Campbell Clinic, University of Tennessee, Memphis, TN 38104, USA. ep1141@hotmail.com
23. Use of the Vectra polyetherurethaneurea graft for dialysis access in HIV-positive patients with end-stage renal disease. Year Published: 2008
Division of Vascular Surgery, University of Miami School of Medicine, Miami, Florida, USA. fschild@med.miami.edu